Search Results - "FRAGA, Carlos A. M"
-
1
The Methylation Effect in Medicinal Chemistry
Published in Chemical reviews (14-09-2011)“…Barreiro et al examine the impact methylation has in medicinal chemistry. Methyl groups are active with regard to metabolism…”
Get full text
Journal Article -
2
Design, Synthesis, and Pharmacological Evaluation of N‑Acylhydrazones and Novel Conformationally Constrained Compounds as Selective and Potent Orally Active Phosphodiesterase‑4 Inhibitors
Published in Journal of medicinal chemistry (13-09-2012)“…Among a small series of tested N-acylhydrazones (NAHs), the compound 8a was selected as a selective submicromolar phosphodiesterase-4 (PDE4) inhibitor…”
Get full text
Journal Article -
3
Cytotoxic and Antiproliferative Activity of LASSBio-2208 and the Attempts to Determine Its Drug Metabolism and Pharmacokinetics In Vitro Profile
Published in Pharmaceuticals (Basel, Switzerland) (01-03-2024)“…Inappropriate expression of histone deacetylase (HDAC-6) and deregulation of the phosphatidylinositol 3-kinase (PI3K) signalling pathway are common aberrations…”
Get full text
Journal Article -
4
Discovery of novel analgesic and anti-inflammatory 3-arylamine-imidazo[1,2- a]pyridine symbiotic prototypes
Published in Bioorganic & medicinal chemistry (2009)“…We describe herein the discovery of LASSBio-1135 ( 3a) as a novel in vivo antinociceptive and anti-inflammatory symbiotic prototype that act as selective…”
Get full text
Journal Article -
5
New insights into pharmacological profile of LASSBio-579, a multi-target N-phenylpiperazine derivative active on animal models of schizophrenia
Published in Behavioural brain research (15-01-2013)“…► The N-phenylpiperazine LASSBio-579 is effective in a model of sensoriomotor gating. ► LASSBio-579 is a multi-target ligand with potential antipsychotic…”
Get full text
Journal Article -
6
Duvelisib: A 2018 Novel FDA-Approved Small Molecule Inhibiting Phosphoinositide 3-Kinases
Published in Pharmaceuticals (Basel, Switzerland) (06-05-2019)“…Duvelisib (Copiktra ) is a dual inhibitor of phosphoinositide 3-kinases (PI3Kδ and PI3Kγ). In 2018, duvelisib was first approved by the Food and Drug…”
Get full text
Journal Article -
7
Understanding the Structural Basis of ALDH-2 Inhibition by Molecular Docking
Published in Medicinal chemistry (Shp-sariqah, United Arab Emirates) (01-09-2016)“…The ALDH-2 enzyme has been identified as an important therapeutic target for the development of new drugs for the treatment of cocaine addiction. Several…”
Get more information
Journal Article -
8
Design, Synthesis, and Pharmacological Evaluation of Novel N‑Acylhydrazone Derivatives as Potent Histone Deacetylase 6/8 Dual Inhibitors
Published in Journal of medicinal chemistry (28-01-2016)“…This manuscript describes a novel class of N-acylhydrazone (NAH) derivatives that act as histone deacetylase (HDAC) 6/8 dual inhibitors and were designed from…”
Get full text
Journal Article -
9
Design, Synthesis, and Pharmacological Profile of Novel Fused Pyrazolo[4,3-d]pyridine and Pyrazolo[3,4-b][1,8]naphthyridine Isosteres: A New Class of Potent and Selective Acetylcholinesterase Inhibitors
Published in Journal of medicinal chemistry (27-03-2003)“…A new family of tacrine (THA) analogues (7−9, 12), containing the azaheterocyclic pyrazolo[4,3-d]pyridine or pyrazolo[3,4-b][1,8]naphthyridine systems as…”
Get full text
Journal Article -
10
Design, synthesis and analgesic properties of novel conformationally-restricted N-acylhydrazones (NAH)
Published in Bioorganic & medicinal chemistry letters (01-09-2009)“…A set of six azaheterocycles were designed as conformationnaly-constrained N-acylhydrazones and tested as analgesics…”
Get full text
Journal Article -
11
Microwave-assisted synthesis and structure–activity relationships of neuroactive pyrazolo[3,4- b]pyrrolo[3,4- d]pyridine derivatives
Published in Bioorganic & medicinal chemistry letters (2010)“…The microwave assisted hetero Diels–Alder synthesis and the sedative profile of heterotricyclic pyrazolo[3,4- b]pyrrolo[3,4- d]pyridine derivatives ( 1a– 1f),…”
Get full text
Journal Article -
12
Discovery of Novel Orally Active Tetrahydro-Naphthyl-N-Acylhydrazones with In Vivo Anti-TNF-α Effect and Remarkable Anti-Inflammatory Properties
Published in PloS one (26-05-2016)“…LASSBio-1524 was designed as inhibitor of the IKK-β (kappa β kinase inhibitor) enzyme, which participates in the activation of the nuclear factor κB (NF-κB)…”
Get full text
Journal Article -
13
Determination of the cardioactive prototype LASSBio-294 and its metabolites in dog plasma by LC–MS/MS: Application for a pharmacokinetic study
Published in Journal of pharmaceutical and biomedical analysis (15-07-2011)“…In this work we describe the evaluation of the pharmacokinetics of a novel cardioactive compound of the N-acylhydrazone class, LASSBio-294, using…”
Get full text
Journal Article -
14
Design and synthesis of new (E)-cinnamic N-acylhydrazones as potent antitrypanosomal agents
Published in European journal of medicinal chemistry (01-08-2012)“…We report herein the synthesis and trypanocidal profile of new (E)-cinnamic N-acylhydrazones (NAHs) designed by exploiting molecular hybridization between the…”
Get full text
Journal Article -
15
Studies towards the identification of putative bioactive conformation of potent vasodilator arylidene N-acylhydrazone derivatives
Published in European journal of medicinal chemistry (01-10-2009)“…In this report we disclose the synthesis, vasodilatory activity, and identification of bioactive conformation of new N-acylhydrazone and N-methyl-…”
Get full text
Journal Article -
16
Antihyperalgesic effects of a novel muscarinic agonist (LASSBio-873) in spinal nerve ligation in rats
Published in Clinical and experimental pharmacology & physiology (01-07-2013)“…Summary New chemicals or adjuvants with analgesic effects on chronic pain are needed and clinically relevant due to the limited number of effective compounds…”
Get full text
Journal Article -
17
Design of new dopamine D2 receptor ligands: Biosynthesis and pharmacological evaluation of the hydroxylated metabolite of LASSBio-581
Published in Bioorganic & medicinal chemistry letters (01-05-2010)“…The biosynthesis of the p-hydroxylated metabolite of LASSBio-581 by Cunninghamella echinulata and its pharmacological evaluation is reported. LASSBio-581 is a…”
Get full text
Journal Article -
18
Design and synthesis of 3,4-methylenedioxy-6-nitrophenoxyacetylhydrazone derivatives obtained from natural safrole: New lead-agents with analgesic and antipyretic properties
Published in Bioorganic & medicinal chemistry (01-12-2006)“…The discovery of the new powerful analgesic and long-lasting antipyretic N-acylhydrazone prototype LASSBio-891 is reported. In this work, we reported the…”
Get full text
Journal Article -
19
N -acylhydrazone derivative ameliorates monocrotaline-induced pulmonary hypertension through the modulation of adenosine AA2R activity
Published in International journal of cardiology (01-05-2014)“…Abstract Background Pulmonary arterial hypertension (PAH) is a disease that results in right ventricular (RV) dysfunction. While pulmonary vascular disease is…”
Get full text
Journal Article -
20
Novel potent imidazo[1,2-a]pyridine-N-Glycinyl-hydrazone inhibitors of TNF-α production: in vitro and in vivo studies
Published in PloS one (14-03-2014)“…In this work, we describe the design, synthesis and pharmacological evaluation of novel imidazo[1,2-a]pyridine-N-glycinyl-hydrazone derivatives (1a-k) intended…”
Get full text
Journal Article